Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
University of Arizona Centocor, Inc. |
---|---|
Information provided by: | University of Arizona |
ClinicalTrials.gov Identifier: | NCT00327275 |
To assess the effects of a 16-week individualized, intensive strength training program in patients with rheumatoid arthritis. Primary and secondary outcomes include: strength and body composition, function, disease activity, pain, quality of life.
We hypothesized that improvements would be seen in all of the above outcomes.
Condition | Intervention |
---|---|
Rheumatoid Arthritis |
Behavioral: strength training |
Study Type: | Interventional |
Study Design: | Randomized, Open Label, Active Control, Single Group Assignment |
Official Title: | The Strength Training and Remicade Study |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Presence of comorbid conditions contraindicated to exercise, including, but not limited to:
United States, Arizona | |
University of Arizona | |
Tucson, Arizona, United States, 85721 |
Principal Investigator: | Hilary G Flint-Wagner, PhD, MPH | Idaho State University |
Study ID Numbers: | 080192 |
Study First Received: | May 16, 2006 |
Last Updated: | May 16, 2006 |
ClinicalTrials.gov Identifier: | NCT00327275 |
Health Authority: | United States: Institutional Review Board |
Autoimmune Diseases Musculoskeletal Diseases Infliximab Joint Diseases |
Arthritis Connective Tissue Diseases Arthritis, Rheumatoid Rheumatic Diseases |
Immune System Diseases |